Brief: BriaCell To Uplist And Trade On Toronto Stock Exchange From TSX Venture Exchange Under 'BCT'; Remains 'BCTX' On Nasdaq
30/12/2021 01:49
Dec 29 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL TO UPLIST AND TRADE ON TORONTO STOCK EXCHANGE
FROM TSX
VENTURE EXCHANGE UNDER 'BCT'; REMAINS 'BCTX' ON NASDAQ
* COMMON SHARES WILL COMMENCE TRADING ON TORONTO STOCK
EXCHANGE
("TSX") AS OF OPENING OF TRADING ON FRIDAY, DECEMBER 31, 2021
* COMMON SHARES WILL CONCURRENTLY BE DE-LISTED FROM TSX
VENTURE
EXCHANGE ("TSX-V") AS OF EFFECTIVE DATE
Source text for Eikon: ID:nGNX6p5dWC
Further company coverage: BCT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study